2021-2031 年北美止咳糖市場報告(範圍、細分、動態和競爭分析)
市場調查報告書
商品編碼
1843381

2021-2031 年北美止咳糖市場報告(範圍、細分、動態和競爭分析)

North America Cough Drops Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

出版日期: | 出版商: The Insight Partners | 英文 126 Pages | 訂單完成後即時交付

價格

北美止咳糖市場預計將大幅成長,到 2031 年將達到約 9.1014 億美元,高於 2023 年的 5.8021 億美元,在此期間的年複合成長率(CAGR) 為 5.8%。

執行摘要和市場分析

北美止咳糖市場呈現穩定成長態勢,這主要得益於消費者對呼吸系統健康的意識不斷增強,以及感冒和流感症狀的增多,尤其是在季節變化期間。市場提供種類繁多的產品,包括薄荷醇類、草本類和無醣類止咳糖,以滿足不同消費者的偏好。美國憑藉其龐大的人口、高昂的醫療支出以及強大的零售網路,佔據了市場主導地位。利口樂 (Ricola)、豪氏 (Halls)(億滋國際)和 Luden's 等主要品牌正在積極創新,推出新口味並添加維生素 C 和鋅等功能性成分,以滿足不斷變化的消費者需求。電子商務的成長以及人們對天然和有機產品的日益青睞,進一步豐富了市場產品種類。此外,新冠疫情 (COVID-19) 疫情加劇了人們對免疫力的關注,導致對治療性潤喉糖的需求增加。隨著人們對預防性醫療保健和健康的興趣日益濃厚,預計北美止咳糖市場在未來幾年將繼續保持上升趨勢。

市場區隔分析

北美止咳藥市場可按產品類型、應用和配銷通路細分:

  • 按產品:市場分為無麩質、無糖和其他類別,其中無糖產品在 2023 年佔據最大的市場佔有率。
  • 按應用:市場分為成人和兒童,其中成人在 2023 年佔更大。
  • 依配銷通路:市場分為線下和線上通路,2023 年線下銷售將占主導地位。線下部分包括零售藥局、超市或大賣場以及醫院藥局。

市場展望

感冒和流感等常見呼吸道疾病是導致喉嚨痛症狀的重要因素。根據世界衛生組織統計,全球每年約有10億例季節性流感病例,其中300萬至500萬例為重症病例。症狀通常在感染後1-4天出現,並永續約一週。普通感冒、流感和季節性過敏的流行推動了對止咳產品的需求,因為消費者希望能夠立即緩解咳嗽和咽喉刺激等症狀。

快速城市化導致空氣品質惡化,引發了人們對呼吸健康的擔憂,導致呼吸系統疾病病例增加。污染物會加劇氣喘和支氣管炎等疾病,促使消費者尋求止咳藥物來緩解症狀。由於免疫力下降和現有的健康問題,老齡人口特別容易患上呼吸系統疾病。世界衛生組織預測,到 2030 年,全球每 6 人中就有 1 人年齡在 60 歲或以上,預計到 2050 年 80 歲及以上人口的數量將增加兩倍。隨著年齡的成長,人們更容易患上需要症狀管理的慢性疾病,包括使用止咳藥。慢性肺部疾病和免疫抑制發生率的上升導致老年人呼吸道感染增加。因此,在呼吸系統疾病負擔日益加重的推動下,製造商正在創新其產品線並建立合作夥伴關係以擴大市場佔有率。

國家洞察

北美止咳糖市場包括美國、加拿大和墨西哥,其中美國在2023年佔最大市場佔有率。美國市場的發展受到消費者偏好變化和對健康保健日益成長的關注的驅動。感冒和過敏等呼吸系統疾病的日益流行,導致非處方止咳和咽喉舒緩產品的需求激增。消費者越來越青睞天然和草藥療法,促使製造商不斷創新,推出包含草藥萃取物、維生素和精油的產品。例如,2021年10月,HALLS與體育解說員喬·巴克合作推出了HALLS minis無糖止咳糖。電子商務改變了止咳糖的購買格局,為消費者提供了更大的可及性和便利性。與傳統零售店相比,線上平台允許產品比較、評論和更廣泛的選擇。呼吸系統疾病的季節性高峰推動了銷售,消費者紛紛購買止咳產品,行銷策略利用社群媒體和線上廣告來吸引年輕族群。

公司簡介

北美止咳糖市場的主要參與者包括 Bliss GVS Pharma Ltd、Cipla Ltd、Gepach International、葛蘭素史克公司 (GSK Plc)、億滋國際 (Mondelez International Inc)、利潔時集團 (Reckitt Benckiser Group Plc)、利口樂 (Ricola)、賽諾菲 (Sanofixer這些公司正在採取各種策略,包括擴張、產品創新和併購,以增強產品線並提高市場佔有率。

目錄

第1章:簡介

第 2 章:執行摘要

  • 關鍵見解

第3章:研究方法

  • 二次研究
  • 初步研究
    • 假設表述:
    • 宏觀經濟因素分析:
    • 顯影基數:
    • 數據三角測量:
    • 國家級資料:
  • 假設和限制

第4章:北美止咳糖市場格局

  • 概述
  • PEST分析

第5章:北美止咳糖市場-關鍵市場動態

  • 北美止咳糖市場-關鍵市場動態
  • 市場促進因素
    • 引起咽喉痛的呼吸系統疾病負擔不斷增加
    • 越來越多選擇自我藥療
  • 市場限制
    • 無法提供長期救濟且缺乏替代方案
  • 市場機會
    • 天然成分和永續包裝備受關注
  • 未來趨勢
    • 採用創新行銷策略
  • 促進因素和限制因素的影響:

第6章:北美止咳糖漿市場 - 分析

  • 2021-2031年北美止咳糖市場收入
  • 北美止咳糖市場預測分析

第7章:北美止咳糖漿市場分析-按產品

  • 不含麩質
  • 無醣
  • 其他

第 8 章:北美止咳糖漿市場分析 - 按應用

  • 成年人
  • 孩子們

第9章:北美止咳糖漿市場分析-按配銷通路

  • 離線
  • 線上

第 10 章:北美止咳糖市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 11 章:產業格局

  • 概述
  • 止咳糖市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第12章:公司簡介

  • Mondelez International Inc
  • The Procter & Gamble Co
  • GSK Plc
  • Cipla Ltd
  • Bliss GVS Pharma Ltd
  • Thornton & Ross
  • Reckitt Benckiser Group Plc
  • Sanofi SA
  • Gepach International
  • Ricola

第 13 章:附錄

Product Code: BMIRE00032009

The North America Cough Drops Market is projected to grow significantly, reaching approximately US$ 910.14 million by 2031, up from US$ 580.21 million in 2023, with a compound annual growth rate (CAGR) of 5.8% during this period.

Executive Summary and Market Analysis

The cough drops market in North America has shown steady growth, primarily due to increased consumer awareness about respiratory health and a rise in cold and flu symptoms, especially during seasonal changes. This market offers a wide range of products, including menthol-based, herbal, and sugar-free cough drops, catering to diverse consumer preferences. The United States dominates the market, benefiting from a large population, significant healthcare expenditures, and a robust retail network. Major brands such as Ricola, Halls (Mondelez), and Luden's are actively innovating by introducing new flavors and incorporating functional ingredients like vitamin C and zinc to meet evolving consumer demands. The growth of e-commerce and a rising preference for natural and organic products have further diversified the market offerings. Additionally, the COVID-19 pandemic has heightened the focus on immunity, leading to increased demand for therapeutic lozenges. With a growing interest in preventive healthcare and wellness, the North America cough drops market is expected to continue its upward trajectory in the coming years.

Market Segmentation Analysis

The North America cough drops market can be segmented by product type, application, and distribution channel:

  • By Product: The market is divided into gluten-free, sugar-free, and other categories, with sugar-free products holding the largest market share in 2023.
  • By Application: The market is categorized into adults and children, with adults accounting for a larger share in 2023.
  • By Distribution Channel: The market is split into offline and online channels, with offline sales dominating in 2023. The offline segment includes retail pharmacies, supermarkets or hypermarkets, and hospital pharmacies.

Market Outlook

Common respiratory issues such as colds and influenza are significant contributors to sore throat symptoms. According to the World Health Organization, around 1 billion cases of seasonal influenza occur globally each year, with 3-5 million cases classified as severe. Symptoms typically manifest 1-4 days post-infection and can last about a week. The prevalence of the common cold, flu, and seasonal allergies drives demand for cough relief products as consumers seek immediate alleviation from symptoms like coughing and throat irritation.

Deteriorating air quality due to rapid urbanization has raised concerns about respiratory health, leading to increased cases of respiratory illnesses. Pollutants exacerbate conditions such as asthma and bronchitis, prompting consumers to seek cough drops for relief. The aging population is particularly susceptible to respiratory disorders due to weakened immunity and existing health issues. The World Health Organization projects that by 2030, 1 in 6 individuals globally will be aged 60 or older, with the number of people aged 80 and above expected to triple by 2050. As individuals age, they are more likely to experience chronic illnesses that necessitate symptom management, including the use of cough drops. The rising incidence of chronic lung diseases and immunosuppression is contributing to increased respiratory infections among older adults. Consequently, manufacturers are innovating their product lines and forming partnerships to expand their market presence, driven by the growing burden of respiratory diseases.

Country Insights

The North America cough drops market includes the US, Canada, and Mexico, with the US holding the largest market share in 2023. The US market is driven by changing consumer preferences and a heightened focus on health and wellness. The increasing prevalence of respiratory conditions, such as colds and allergies, has led to a surge in demand for over-the-counter cough and throat-soothing products. Consumers are increasingly favoring natural and herbal remedies, prompting manufacturers to innovate with products that include herbal extracts, vitamins, and essential oils. For example, in October 2021, HALLS launched HALLS minis Sugar-Free Cough Drops in collaboration with sportscaster Joe Buck. E-commerce has transformed the purchasing landscape for cough drops, providing consumers with greater accessibility and convenience. Online platforms allow for product comparisons, reviews, and a wider selection than traditional retail stores. Seasonal peaks in respiratory illnesses drive sales as consumers stock up on cough relief products, with marketing strategies leveraging social media and online advertising to engage younger demographics.

Company Profiles

Key players in the North America cough drops market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:
  • 3.3 Assumptions and Limitations

4. North America Cough Drops Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. North America Cough Drops Market - Key Market Dynamics

  • 5.1 North America Cough Drops Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Burden of Respiratory Diseases Causing Sore Throat
    • 5.2.2 Increasing Shift Toward Self-Medication
  • 5.3 Market Restraints
    • 5.3.1 Inability to Provide Long-Term Relief and Availability of Alternatives
  • 5.4 Market Opportunities
    • 5.4.1 Surging Focus on Natural Ingredients and Sustainable Packaging
  • 5.5 Future Trends
    • 5.5.1 Adoption of Innovative Marketing Strategies
  • 5.6 Impact of Drivers and Restraints:

6. North America Cough Drops Market - Analysis

  • 6.1 North America Cough Drops Market Revenue (US$ Million), 2021-2031
  • 6.2 North America Cough Drops Market Forecast Analysis

7. North America Cough Drops Market Analysis - by Product

  • 7.1 Gluten Free
    • 7.1.1 Overview
    • 7.1.2 Gluten Free: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Sugar Free
    • 7.2.1 Overview
    • 7.2.2 Sugar Free: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Others
    • 7.3.1 Overview
    • 7.3.2 Others: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Cough Drops Market Analysis - by Application

  • 8.1 Adults
    • 8.1.1 Overview
    • 8.1.2 Adults: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Children
    • 8.2.1 Overview
    • 8.2.2 Children: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Cough Drops Market Analysis - by Distribution Channel

  • 9.1 Offline
    • 9.1.1 Overview
    • 9.1.2 Offline: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Online
    • 9.2.1 Overview
    • 9.2.2 Online: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. North America Cough Drops Market - Country Analysis

  • 10.1 North America
    • 10.1.1 North America Cough Drops Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 North America Cough Drops Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 United States: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 United States: North America Cough Drops Market Share - by Product
        • 10.1.1.2.2 United States: North America Cough Drops Market Share - by Application
        • 10.1.1.2.3 United States: North America Cough Drops Market Share - by Distribution Channel
        • 10.1.1.2.4 United States: North America Cough Drops Market Share - by Offline
      • 10.1.1.3 Canada: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Canada: North America Cough Drops Market Share - by Product
        • 10.1.1.3.2 Canada: North America Cough Drops Market Share - by Application
        • 10.1.1.3.3 Canada: North America Cough Drops Market Share - by Distribution Channel
        • 10.1.1.3.4 Canada: North America Cough Drops Market Share - by Offline
      • 10.1.1.4 Mexico: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 Mexico: North America Cough Drops Market Share - by Product
        • 10.1.1.4.2 Mexico: North America Cough Drops Market Share - by Application
        • 10.1.1.4.3 Mexico: North America Cough Drops Market Share - by Distribution Channel
        • 10.1.1.4.4 Mexico: North America Cough Drops Market Share - by Offline

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Cough Drops Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Mondelez International Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 The Procter & Gamble Co
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 GSK Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Cipla Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bliss GVS Pharma Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Thornton & Ross
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Reckitt Benckiser Group Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Financial Overview
    • 12.7.4 SWOT Analysis
    • 12.7.5 Key Developments
  • 12.8 Sanofi SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Gepach International
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Ricola
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Cough Drops Market Segmentation
  • Table 2. List of Vendors
  • Table 3. North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 4. North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product
  • Table 5. North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 6. North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Distribution Channel
  • Table 7. North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 8. United States: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 9. United States: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 10. United States: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 11. United States: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offline
  • Table 12. Canada: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 13. Canada: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 14. Canada: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 15. Canada: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offline
  • Table 16. Mexico: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
  • Table 17. Mexico: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. Mexico: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
  • Table 19. Mexico: North America Cough Drops Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offline
  • Table 20. List of Abbreviations

List Of Figures

  • Figure 1. North America Cough Drops Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Cough Drops Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Cough Drops Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Gluten Free: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Sugar Free: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Others: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. North America Cough Drops Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Adults: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Children: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. North America Cough Drops Market Share (%) - by Distribution Channel (2023 and 2031)
  • Figure 13. Offline: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Online: North America Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. North America Cough Drops Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 16. United States: North America Cough Drops Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 17. Canada: North America Cough Drops Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 18. Mexico: North America Cough Drops Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 19. Heat Map Analysis by Key Players
  • Figure 20. Company Positioning and Concentration